WAVE Life Sciences Ltd
NASDAQ:WVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
SG |
|
Limbach Holdings Inc
NASDAQ:LMB
|
US |
|
ARYx Therapeutics Inc
OTC:ARYX
|
US |
|
Bank Pan Indonesia Tbk PT
IDX:PNBN
|
ID |
|
O
|
Opus One Gold Corp
XTSX:OOR
|
CA |
|
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
|
US |
|
Lycopodium Ltd
ASX:LYL
|
AU |
|
Idaho Copper Corp
OTC:COPR
|
US |
|
Kuros Biosciences AG
SIX:KURN
|
CH |
|
Australian Finance Group Ltd
ASX:AFG
|
AU |
|
Fursys Inc
KRX:016800
|
KR |
Profitability Summary
WAVE Life Sciences Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
WAVE Life Sciences Ltd
Margins Comparison
WAVE Life Sciences Ltd Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| SG |
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
1.4B USD |
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
908.9B USD |
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.1B USD |
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.6B GBP |
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.1B CHF |
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.6B USD |
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.7B USD |
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
WAVE Life Sciences Ltd Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| SG |
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
1.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
908.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
